YM BioSciences Reports Phase I/II Data for JAK Inhibitor CYT387 at ASH 2012

News   Dec 11, 2012

 
YM BioSciences Reports Phase I/II Data for JAK Inhibitor CYT387 at ASH 2012
 
 
FURTHER INFORMATION
 
 
 
 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE